Overall Cardiovascular Risk Assessment

Overall cardiovascular risk assessment is the use of multivariable risk-prediction tools to combine an individual's measured risk factors — such as age, sex, blood pressure, lipids, smoking, and diabetes status — into a single estimate of their probability of a cardiovascular event over a defined period, typically ten years. It is the integrating step that turns separate screening results into a total-risk picture.

Definition

Overall cardiovascular risk assessment is the estimation of an individual's total probability of a cardiovascular event over a defined horizon by combining multiple measured risk factors using a validated multivariable prediction model.

Scope

The entry covers the rationale for estimating total cardiovascular risk rather than treating risk factors in isolation, the major families of risk-prediction equations, and the importance of using region- and population-appropriate tools. It is a reference description of the risk-estimation concept and its evidence; it does not prescribe risk thresholds, treatment decisions, or tools for any individual.

Core questions

• Why estimate total cardiovascular risk instead of considering each risk factor separately?
• What inputs do multivariable risk-prediction equations use, and what do they output?
• Why must risk tools be calibrated to the population in which they are used?

Key concepts

• Multivariable risk prediction
• 10-year absolute risk estimate
• Framingham risk functions and pooled cohort equations
• SCORE2 / region-calibrated models
• Model calibration and discrimination
• Total versus single-factor risk

Mechanisms

Cardiovascular risk factors act together, and their combined effect on event probability is captured by multivariable equations fitted to long-term cohort data. Such tools take inputs such as age, sex, smoking status, blood pressure, and lipid levels and output an estimated absolute risk over a defined horizon. Because the underlying event rates differ between populations, equations are calibrated to specific regions or recalibrated when applied elsewhere; the SCORE2 models, for example, were derived and calibrated across European risk regions (SCORE2 working group, 2021). Performance is judged by discrimination (separating those who will and will not have events) and calibration (agreement between predicted and observed risk).

Clinical relevance

Total cardiovascular risk estimation underpins primary-prevention frameworks and shared decision-making about risk reduction. This entry describes the risk-assessment concept and its evidence; it characterizes how risk is estimated at the population level and is not a guide to deciding treatment for an individual. For the use of cardiovascular risk estimation specifically in the surgical setting, see the related preoperative cardiovascular-risk-assessment entry.

Epidemiology

Multivariable risk tools are embedded in cardiovascular prevention guidelines worldwide and are applied across large adult populations to stratify risk and prioritize prevention. Their predictions depend on the event rates of the populations from which they were derived, which is why regionally calibrated models are emphasized (Visseren et al., 2021; SCORE2 working group, 2021).

Evidence & guidelines

The Framingham risk functions (Wilson et al., 1998) introduced widely used multivariable estimation, the 2013 ACC/AHA guideline introduced the pooled cohort equations (Goff et al., 2014), and the European SCORE2 algorithms provide contemporary region-calibrated estimation (SCORE2 working group, 2021). The 2021 ESC prevention guidelines situate total-risk estimation at the centre of preventive decision-making (Visseren et al., 2021).

History

Total cardiovascular risk estimation originated with the Framingham Heart Study, whose multivariable functions translated cohort data into individual risk predictions (Wilson et al., 1998). Subsequent tools — including the pooled cohort equations (Goff et al., 2014) and the SCORE/SCORE2 systems (SCORE2 working group, 2021) — refined and regionalized this approach as the importance of population calibration became clear.

Debates

How transportable are risk equations across populations?

Risk models derived in one population often over- or under-estimate risk in another because baseline event rates differ, so calibration or region-specific derivation (as in SCORE2) is needed, and the choice of tool remains a methodological judgement.

Seminal works

• wilson-1998
• goff-2014
• score2-2021

Frequently asked questions

Why estimate total cardiovascular risk instead of treating each risk factor alone?

Risk factors act together, so a person with several moderately abnormal factors can be at higher total risk than someone with one markedly abnormal factor; multivariable tools capture this combined effect in a single estimate.

Why does the choice of risk tool depend on the population?

Risk equations are calibrated to the event rates of the populations they were built from, so applying a tool to a different population can misestimate risk unless the model is recalibrated or a region-specific tool such as SCORE2 is used.